...
首页> 外文期刊>Cells tissues organs >Verification of the Inactivation of Melanocytic Nevus in vitro Using a Newly Developed Portable High Hydrostatic Pressure Device
【24h】

Verification of the Inactivation of Melanocytic Nevus in vitro Using a Newly Developed Portable High Hydrostatic Pressure Device

机译:使用新开发的便携式高静压装置在体外验证体外痣的灭活

获取原文
获取原文并翻译 | 示例
           

摘要

High hydrostatic pressure (HHP) technology is a physical method for inactivating tissue. We reported that nevus specimens were inactivated after HHP at 200 MPa and that the inactivated nevus could be used as autologous dermis for covering skin defects. In this study, we verified the inactivation of nevus specimens using a newly developed portable HHP device which will be used in a clinical trial. Nevus tissue specimens were obtained from 5 patients (mean age 7.2 years, range 1-19). We cultured fibroblasts and nevus cells from the tissue specimens and then evaluated their inactivation after HHP at 200 MPa by confirming the attachment of the suspensions and by the live/dead staining of the suspensions, through the dissociation of the cells on chamber slides and by the live/dead staining of the remaining cells. The cells were also quantitatively evaluated by WST-8 assay. We then confirmed the inactivation of the nevus specimens after HHP using explant culture. Our results indicated that fibroblasts and nevus cells were inactivated after HHP at 200 MPa, with the exception of a small percentage of green-colored cells,which reflected the remaining activity of the cellular ester-ases after HHP. No cells migrated from the nevus specimens after HHP at 200 MPa. We verified the inactivation of fibroblasts and nevus cells cultured from nevus specimens, and in the nevus samples themselves after pressurization at 200 MPa using this device. This device could be used in clinical trials for giant congenital melanocytic nevi and may thus become useful in VariOUS medical fields.
机译:高静水压压力(HHP)技术是用于灭活组织的物理方法。我们报道,在HHP的HHP下,200MPa的痣样本灭活,灭活的痣可用作覆盖皮肤缺陷的自体皮肤。在这项研究中,我们使用新开发的便携式HHP装置验证了痣样本的灭活,该装置将用于临床试验。痣组织标本是从5名患者获得(平均年龄7.2岁,范围1-19)。从组织标本中培养成纤维细胞和痣细胞,然后通过确认悬浮液的附着并通过悬浮液的活性/死染料,通过腔室载玻片上的细胞和通过剩余细胞的实时/死亡染色。通过WST-8测定,细胞也定量评估。然后,我们在使用外植体培养后确认了HHP后痣样本的灭活。我们的结果表明,在200MPa的HHP下灭活成纤维细胞和痣细胞,除了小百分比的绿色细胞,其反映了HHP后细胞酯类的剩余活性。 HHP在200MPa的HHP后没有从痣样品中迁移的细胞。我们验证了从痣样品培养的成纤维细胞和痣细胞的灭活,并且在使用该装置在200MPa的加压后自身在痣上样品。该装置可用于巨型先天性黑素细胞痣的临床试验,因此可以在各种医用领域中获得可用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号